⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL266970 | 0.92 | — | — | |
| SCHEMBL17904152 | 0.89 | INMT (0.39) | — | |
| Iodide SCHEMBL28973917 | 0.89 | — | — | |
| SCHEMBL9945743 | 0.89 | — | — | |
| SCHEMBL17297100 | 0.89 | INMT (0.39) | — | |
| SCHEMBL15090048 | 0.89 | INMT (0.39) | — | |
| SCHEMBL16204305 | 0.89 | INMT (0.39) | — | |
| SCHEMBL16020841 | 0.89 | INMT (0.39) | — | |
| SCHEMBL12256345 | 0.78 | — | — | |
| SCHEMBL7037075 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992018548-A1 | NOVEL COMPOSITION FOR CONTACT LENSES | OPTICAL RESEARCH, INC. (US) | 1992-10-29 | — | — | WO | claimed |
| WO-2023009833-A9 | MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2023-11-23 | — | — | WO | disclosed |
| US-11818942-B2 | Liquid formulation and a method for making electronic devices by solution process | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-11-14 | — | — | US | disclosed |
| WO-2023205475-A1 | CTPS1 INHIBITORS AND USES THEREOF | NIMBUS CLOTHO, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| US-11795147-B2 | Modulators of complex I | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2023-10-24 | — | — | US | disclosed |
| US-11795147-B2 | Modulators of complex I | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2023-10-24 | — | — | US | disclosed |
| US-11753492-B2 | Acryloyl based polymers with active end cap as corrosion inhibitors | SAUDI ARABIAN OIL COMPANY (SA) | 2023-09-12 | — | — | US | disclosed |
| US-20230265096-A1 | APOL1 INHIBITORS AND METHODS OF USE | HERCULES CAPITAL, INC., AS AGENT | 2023-08-24 | — | — | US | disclosed |
| US-20230251578-A1 | METHOD FOR FORMING SEMICONDUCTOR STRUCTURE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2023-08-10 | — | — | US | disclosed |
| US-20230167221-A1 | COPOLYMERS OF (3-ACRYLAMIDOPROPYL)TRIMETHYL AMMONIUM CHLORIDE AS CORROSION INHIBITOR INTERMEDIATE | SAUDI ARABIAN OIL COMPANY (SA) | 2023-06-01 | — | — | US | disclosed |
| EP-1995240-A1 | QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Astellas Pharma Inc. (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-20070299068-A1 | Methods for treating hepatitis C | PTC THERAPEUTICS, INC. | 2007-12-27 | — | — | US | disclosed |
| US-20070232805-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | INVITROGEN CORPORATION (US) | 2007-10-04 | — | — | US | disclosed |
| US-20070178512-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | INVITROGEN CORPORATION (US) | 2007-08-02 | — | — | US | disclosed |
| US-20070178511-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | INVITROGEN CORPORATION (US) | 2007-08-02 | — | — | US | disclosed |
| US-20070004644-A1 | Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia | SIRCAR JAGADISH C | 2007-01-04 | — | — | US | disclosed |
| US-4353913-A | ANTHELMINTICS | BAYER AKTIENGESELLSCHAFT (DE) | 1982-10-12 | — | — | US | disclosed |
| EP-0010242-B1 | BENZIMIDAZOLYL-2-CARBAMIC ACID ESTERS, MEDICAMENTS BASED THEREON AND PROCESS FOR THEIR PREPARATION | BAYER AG (DE) | 1982-09-29 | — | — | EP | disclosed |
| US-4287199-A | USEFUL AS ANTHELMINITICS | BAYER AKTIENGESELLSCHAFT (DE) | 1981-09-01 | — | — | US | disclosed |
| EP-0010242-A1 | Benzimidazolyl-2-carbamic acid esters, medicaments based thereon and process for their preparation | BAYER AG (DE) | 1980-04-30 | — | — | EP | disclosed |